LUNG DEPOSITION OF BUDESONIDE INHALED VIA TURBUHALER(R) - A COMPARISON WITH TERBUTALINE SULFATE IN NORMAL SUBJECTS

被引:236
作者
BORGSTROM, L
BONDESSON, E
MOREN, F
TROFAST, E
NEWMAN, SP
机构
[1] NOVECON RES AB,S-22370 LUND,SWEDEN
[2] ROYAL FREE HOSP,DEPT THORAC MED,LONDON NW3 2QG,ENGLAND
[3] UNIV LONDON SCH MED,LONDON,ENGLAND
关键词
AEROSOL DEPOSITION; ASTHMA; BUDESONIDE; POWDER INHALER; TERBUTALINE SULFATE;
D O I
10.1183/09031936.94.07010069
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
We wanted to evaluate whether lung deposition of budesonide and terbutaline sulphate differs, and to determine lung deposition of budesonide inhaled at different peak inspiratory flows, through Turbuhaler(R). Lung deposition of budesonide, a lipophilic substance, and of terbutaline sulphate, a hydrophilic substance, was therefore compared, after administration via an inspiratory flow-driven, multi-dose, powder inhaler Turbuhaler(R), Astra Draco AB) to 10 healthy volunteers The radionuclide Tc-99m was used to label drug particles, and radioactivity, indicating drag deposition, was measured using a gamma camera. Budesonide was inhaled at a normal now of 58 l.min(-1) and at a slow flow of 36 l.min(-1). At the faster how, a mean+/-SD 27.7+/-9.5% of the metered dose was deposited in the hmg and at the slower Row 14.8+/-3.3% was deposited (p<0.001). Mean lung deposition of terbutaline sulphate inhaled at 57 l.min(-1) was 27+/-7.7%. We conclude that inspiratory now has an important effect on lung deposition, hut water solubility appears to have no effect.
引用
收藏
页码:69 / 73
页数:5
相关论文
共 21 条
[1]   RESPIRATORY-TRACT DEPOSITION OF SODIUM CROMOGLYCATE IS HIGHLY DEPENDENT UPON TECHNIQUE OF INHALATION USING THE SPINHALER [J].
AUTY, RM ;
BROWN, K ;
NEALE, MG ;
SNASHALL, PD .
BRITISH JOURNAL OF DISEASES OF THE CHEST, 1987, 81 (04) :371-380
[2]  
Biddiscombe M, 1991, J AEROSOL MED S1, V4, P9
[3]   THE LUNG DEPOSITION OF SALBUTAMOL, DIRECTLY LABELED WITH TC-99M, DELIVERED BY PRESSURIZED METERED-DOSE AND DRY POWDER INHALERS [J].
BIDDISCOMBE, MF ;
MELCHOR, R ;
MAK, VHF ;
MARRIOTT, RJ ;
TAYLOR, AJ ;
SHORT, MD ;
SPIRO, SG .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 91 (2-3) :111-121
[4]   PULMONARY DEPOSITION OF INHALED TERBUTALINE - COMPARISON OF SCANNING GAMMA-CAMERA AND URINARY-EXCRETION METHODS [J].
BORGSTROM, L ;
NEWMAN, S ;
WEISZ, A ;
MOREN, F .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (08) :753-755
[5]   A METHOD FOR DETERMINATION OF THE ABSOLUTE PULMONARY BIOAVAILABILITY OF INHALED DRUGS - TERBUTALINE [J].
BORGSTROM, L ;
NILSSON, M .
PHARMACEUTICAL RESEARCH, 1990, 7 (10) :1068-1070
[6]   TOTAL AND REGIONAL LUNG DEPOSITION OF TERBUTALINE SULFATE INHALED VIA A PRESSURIZED MDI OR VIA TURBUHALER (R) [J].
BORGSTROM, L ;
NEWMAN, S .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 97 (1-3) :47-53
[7]  
BROWN PH, 1992, THORAX, V47, P239
[8]  
CROMPTON GK, 1990, LUNG S, P658
[9]  
DIRKSEN H, 1983, EUR J RESPIR DIS, V64, P48
[10]   CLINICAL COMPARISON OF INHALED BUDESONIDE DELIVERED EITHER VIA PRESSURIZED METERED DOSE INHALER OR TURBUHALER [J].
ENGEL, T ;
HEINIG, JH ;
MALLING, HJ ;
SCHARLING, B ;
NIKANDER, K ;
MADSEN, F .
ALLERGY, 1989, 44 (03) :220-225